ifosfamide has been researched along with Cancer of Endometrium in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy." | 9.08 | Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996) |
| "Fifty-two patients with advanced adenocarcinoma of the endometrium recurrent after surgery and/or radiation therapy and refractory to first-line chemotherapeutic agents were treated with ifosfamide, 1." | 9.07 | Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study. ( Adcock, L; Blessing, JA; Homesley, HD; McGuire, WP; Sutton, GP, 1994) |
| "To determine the effectiveness and toxicity of ifosfamide chemotherapy in women with metastatic or recurrent endometrial stromal sarcomas unexposed to other chemotherapy." | 5.08 | Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group. ( Blessing, JA; DiSaia, PJ; Park, R; Rosenshein, N; Sutton, G, 1996) |
| "Fifty-two patients with advanced adenocarcinoma of the endometrium recurrent after surgery and/or radiation therapy and refractory to first-line chemotherapeutic agents were treated with ifosfamide, 1." | 5.07 | Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study. ( Adcock, L; Blessing, JA; Homesley, HD; McGuire, WP; Sutton, GP, 1994) |
| "Ifosfamide is an active drug in the treatment of chemotherapy-naive patients with advanced endometrial cancer and its application in currently used (combination) regimens should be considered." | 2.69 | Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group. ( Boes, GH; Cervantes, A; Hoesel, G; Pawinski, A; Pecorelli, S; Tumolo, S; van Oosterom, AT, 1999) |
| "In epithelial ovarian cancer, responses were observed in eight (20%) of 41 evaluable patients, with three (7%) complete responses." | 2.38 | Gynecologic Oncology Group studies with ifosfamide. ( Blessing, JA; Homesley, H; Manetta, A; McGuire, W; Sutton, GP, 1992) |
| "Women with stage III-IV endometrial cancer treated with concurrent chemotherapy and radiation between 2006 and 2013 were included." | 1.40 | Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer. ( Al-Hammadi, N; Binder, PS; Fuh, K; Grigsby, P; Hagemann, A; Mutch, D; Pourabolghasem, S; Powell, M; Schwarz, J; Thaker, P; Wilkinson-Ryan, I, 2014) |
| "Uterine mullerian adenosarcoma is a rare tumor without specific clinical symptoms and signs." | 1.36 | [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases]. ( Guo, LN; Han, XY; Huang, HF; Pan, LY; Sheng, K; Wan, XR; Xiang, Y, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (46.15) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (46.15) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, S | 1 |
| Hirai, S | 1 |
| Katayama, T | 1 |
| Eto, T | 1 |
| Saito, T | 1 |
| Shimokawa, M | 1 |
| Hatae, M | 1 |
| Takeshima, N | 2 |
| Kobayashi, H | 1 |
| Kasamatsu, T | 1 |
| Yoshikawa, H | 1 |
| Kamura, T | 1 |
| Konishi, I | 1 |
| Wilkinson-Ryan, I | 1 |
| Binder, PS | 1 |
| Pourabolghasem, S | 1 |
| Al-Hammadi, N | 1 |
| Fuh, K | 1 |
| Hagemann, A | 1 |
| Thaker, P | 1 |
| Schwarz, J | 1 |
| Grigsby, P | 1 |
| Mutch, D | 1 |
| Powell, M | 1 |
| Sueoka, K | 1 |
| Umayahara, K | 1 |
| Abe, A | 1 |
| Usami, T | 1 |
| Yamamoto, A | 1 |
| Nomura, H | 1 |
| Matoda, M | 1 |
| Okamoto, S | 1 |
| Omatsu, K | 1 |
| Kondo, E | 1 |
| Kato, K | 1 |
| Miolo, G | 1 |
| Viel, A | 1 |
| Canzonieri, V | 1 |
| Baresic, T | 1 |
| Buonadonna, A | 1 |
| Santeufemia, DA | 1 |
| Lara, DP | 1 |
| Corona, G | 1 |
| Han, XY | 1 |
| Xiang, Y | 1 |
| Guo, LN | 1 |
| Sheng, K | 1 |
| Wan, XR | 1 |
| Huang, HF | 1 |
| Pan, LY | 1 |
| Ushijima, M | 1 |
| Yamakawa, Y | 1 |
| Sakabe, E | 1 |
| Waki, H | 1 |
| Katou, K | 1 |
| Sutton, GP | 3 |
| Blessing, JA | 4 |
| Homesley, HD | 1 |
| McGuire, WP | 1 |
| Adcock, L | 1 |
| Sutton, G | 1 |
| Park, R | 1 |
| DiSaia, PJ | 1 |
| Rosenshein, N | 1 |
| DeMars, LR | 1 |
| Moore, D | 1 |
| Burke, TW | 1 |
| Grendys, EC | 1 |
| Yamawaki, T | 1 |
| Shimizu, Y | 1 |
| Hasumi, K | 1 |
| Pawinski, A | 1 |
| Tumolo, S | 1 |
| Hoesel, G | 1 |
| Cervantes, A | 1 |
| van Oosterom, AT | 1 |
| Boes, GH | 1 |
| Pecorelli, S | 1 |
| Manetta, A | 1 |
| Homesley, H | 1 |
| McGuire, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Evaluation of Quality of Life and Treatment-related Side Effects of Women Undergoing Multimodality Treatment for Advanced Stage Endometrial Carcinoma[NCT04743999] | Phase 2 | 60 participants (Anticipated) | Interventional | 2020-02-27 | Recruiting | ||
| Endometrial Stromal Tumors: an Observational Study[NCT02829437] | 100 participants (Anticipated) | Observational | 2016-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for ifosfamide and Cancer of Endometrium
| Article | Year |
|---|---|
Gynecologic Oncology Group studies with ifosfamide.
Topics: Adenocarcinoma; Carcinoma; Clinical Trials, Phase II as Topic; Endometrial Neoplasms; Female; Genita | 1992 |
4 trials available for ifosfamide and Cancer of Endometrium
| Article | Year |
|---|---|
Phase II study of ifosfamide and mesna in refractory adenocarcinoma of the endometrium. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Combined Modality Therapy; Endometrial Neoplasms; Female; H | 1994 |
Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group.
Topics: Antineoplastic Agents, Alkylating; Drug Administration Schedule; Endometrial Neoplasms; Female; Huma | 1996 |
A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Endometrial Neoplasms; Fe | 1996 |
Cyclophosphamide or ifosfamide in patients with advanced and/or recurrent endometrial carcinoma: a randomized phase II study of the EORTC Gynecological Cancer Cooperative Group.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents, Alkylating; Cyclophosphamide; Endometrial Neopla | 1999 |
8 other studies available for ifosfamide and Cancer of Endometrium
| Article | Year |
|---|---|
[Lung Metastasis from High-grade Uterine Endometrial Stromal Sarcoma;Report of a Case].
Topics: Aged; Endometrial Neoplasms; Female; Heparin; Humans; Ifosfamide; Lung Neoplasms; Sarcoma, Endometri | 2020 |
Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuva | 2013 |
Concomitant chemotherapy and radiation for the treatment of advanced-stage endometrial cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemora | 2014 |
Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
Topics: Adenocarcinoma, Clear Cell; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin | 2015 |
Association of the germline BRCA2 missense variation Glu2663Lys with high sensitivity to trabectedin-based treatment in soft tissue sarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bone Neoplasms; BRCA2 Protein; Dioxol | 2016 |
[Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Topics: Adenosarcoma; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuv | 2010 |
[A case of recurrent high-grade endometrial stromal sarcoma controlled by a combination of Ifosfamide, adriamycin, and cisplatin].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxorubicin; Endomet | 2010 |
Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Doxoru | 1997 |